Journal of Huazhong University of Science and Technology [Medical Sciences]

, Volume 32, Issue 4, pp 511–516

Establishment of reproducible xenotransplantation model of T cell acute lymphoblastic leukemia in NOD/SCID mice

  • Di Wang王 迪
  • Na Wang王 娜
  • Yan Zhang张 艳
  • Shuyan Ma马淑燕
  • Zhe Geng耿 哲
  • Pengfei Zhou周鹏飞
  • Jianfeng Zhou周剑峰
  • Liang Huang黄 亮
Article

DOI: 10.1007/s11596-012-0088-5

Cite this article as:
Wang, D., Wang, N., Zhang, Y. et al. J. Huazhong Univ. Sci. Technol. [Med. Sci.] (2012) 32: 511. doi:10.1007/s11596-012-0088-5

Summary

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive leukemia. However the poor prognosis and low morbidity restrict further analysis of the disease. Therefore there is an increasing demand to develop animal models for identifying novel therapeutic approaches. In this study, we inoculated the anti-mouse CD122 monoclonal antibody conditioned NOD/SCID mice with the leukemia cells from 9 T-ALL patients and 1 cell line via the tail vein. Four of the 9 patients and the cell line were successfully engrafted. Flow cytometry detected high percentage of human CD45+ cells in recipient mice. Immunohistochemistry showed infiltration of human CD45+ cells in different organs. Serial transplantation was also achieved. In vivo drug treatment showed that dexamethasone could extend survival, which was consistent with clinical observation. These results demonstrated that we successfully established 5 xenotransplantation models of T-ALL in anti-mCD122 mAb conditioned NOD/SCID mice, which recapitulated the characteristics of original disease.

Key words

T cell acute lymphoblastic leukemiaxenotransplantationNOD/SCID micein vivo

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Di Wang王 迪
    • 1
  • Na Wang王 娜
    • 1
  • Yan Zhang张 艳
    • 2
  • Shuyan Ma马淑燕
    • 2
  • Zhe Geng耿 哲
    • 1
  • Pengfei Zhou周鹏飞
    • 2
  • Jianfeng Zhou周剑峰
    • 1
  • Liang Huang黄 亮
    • 1
  1. 1.Department of Hematology, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.Crown Bioscience Inc. (Beijing)BeijingChina